Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexalin Technology (NXL) Research & Development (2024 - 2025)

Historic Research & Development for Nexalin Technology (NXL) over the last 2 years, with Q3 2025 value amounting to $226520.0.

  • Nexalin Technology's Research & Development rose 2685.58% to $226520.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 3803.32% down from last year.
  • Nexalin Technology's Research & Development amounted to $226520.0 in Q3 2025, which was up 2685.58% from $225774.0 recorded in Q2 2025.
  • Over the past 5 years, Nexalin Technology's Research & Development peaked at $737242.0 during Q4 2024, and registered a low of $105668.0 during Q1 2024.